New medicines in our portfolio

  1. Libtayo (cemiplimab-rwlc)
    Libtayo (cemiplimab-rwlc)
    by Sanofi
    for Skin Cancer
    €17,380.00
View as Grid List

1 Item

per page
Set Descending Direction